Response of Rhodospirillum rubrum S1H to three pharmaceuticals

ABSTRACT: The present study explores the potential of compound-specific gene-upregulation profiles in the ubiquitous purple nonsulfur bacterium Rhodospirillum rubrum S1H as biomarkers for exposure to surface water contaminants, i.e. high production-volume pharmaceuticals. Even though the pharmaceuticals [i.e., acetylsalicylic acid (ASA), diclofenac (DCF), and 17M-NM-1-ethinylestradiol (EE2)] did not affect the bacterial growth kinetics at environmentally-relevant concentrations (86nM), whole-genome microarray analyses revealed the upregulation of 128, 49, and 47 genes upon exposure to DCF, ASA, and EE2, respectively. A strong overlap (27-48%) was observed between transcriptional responses, but a total of 93 genes were found to be upregulated in a compound-specific manner. Hence, we were able to iden

ORGANISM(S): Rhodospirillum rubrum

SUBMITTER: Pieter Monsieurs 

PROVIDER: E-GEOD-23794 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress